Concepedia

Irving H. Fox

IH

Statistics

Publications

108

Citations

14.6K

H-Index

48

Active since

1970

Affiliations

University of Michigan(Current)

Western University

Takeda (United States)

Millennium Engineering and Integration (United States)

University of Toronto

Irving H. Fox is an author at University of Michigan specializing in life sciences, biochemistry, and pharmacology.

Publications per year

1970–2017

108

Publications

108

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine · 2013 · 2.9K citations · Full text

, , +15

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

William J. Sandborn, Brian G. Feagan, Paul Rutgeerts et al. · New England Journal of Medicine · 2013 · 2.7K citations · Full text

, , +14

The safety of vedolizumab for ulcerative colitis and Crohn's disease

Jean‐Frédéric Colombel, Bruce E. Sands, Paul Rutgeerts et al. · Gut · 2016 · 803 citations · Full text

, , +10

Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed

Bruce E. Sands, Brian G. Feagan, Paul Rutgeerts et al. · Gastroenterology · 2014 · 705 citations · Full text

, , +15

Treatment of Ulcerative Colitis with a Humanized Antibody to the α <sub>4</sub> β <sub>7</sub> Integrin

Brian G. Feagan, Gordon R. Greenberg, Gary Wild et al. · New England Journal of Medicine · 2005 · 694 citations · Full text

, , +17

1–5 of 108